Rafael Gual
Expert Contributor
Rafael Gual
Director General
CANIFARMA
https://mx.linkedin.com/in/rafael-gual-cos%C3%ADo-a316a538
https://twitter.com/rafa_gual_c
http://canifarma.org.mx/
1
How are ethical business practices promoted in the pharmaceutical industry? Rafael Gual provides an answer.
jake-nebov-seTS7bvcr0A-unsplash (1).jpg
Analysis
After the pandemic, global supply chains are restructuring their capabilities and Mexico stands to benefit from manufacturing nearshoring.
jorge-aguilar-vZ9TqSm9ZsQ-unsplash.jpg
Analysis
Advances and ongoing challenges have paved the way for the transformation of Mexico’s health system.
MHSEcho-img-2022-IN-01-1245-Pharmacoeconomics
News Article
Healthcare providers are embracing pharmacoeconomics to make better decisions, but the field must also improve.
Rafael Gual
Expert Contributor
Rafael Gual
Director General
National Chamber of the Pharmaceutical Industry
https://mx.linkedin.com/in/rafael-gual-cos%C3%ADo-a316a538
https://twitter.com/rafa_gual_c
http://canifarma.org.mx/
0
Rafael Gual looks at the pharmaceutical industry in Mexico, discussing its relevance from both a social and economic viewpoint.
ksenia-yakovleva-YT6COuf1gY0-unsplash.jpg (
News Article
The new acquisition law caused medicine shortages, with 24 million prescriptions being left unfilled at public health institutions.
MHS 2022
News Article
An open dialogue between the public and private sectors is required to deliver medical supplies to patients across Mexico, agreed industry experts.
National Pharmaceutical Policy Aims to Solve Supply Gaps
News Article
In an attempt to solve the third consecutive year of medicine shortages, the government is changing medicine acquisition processes.
COFEPRIS’s recent update is expected to spur innovation on drug therapies and encourage investment on innovation.
News Article
COFEPRIS’s recent update is expected to spur innovation on drug therapies and encourage investment on innovation.
Subscribe to CANIFARMA